trending Market Intelligence /marketintelligence/en/news-insights/trending/JY3HujrMvehrAd9Vf6QEMw2 content esgSubNav
In This List

Clementia prices IPO

Blog

Insight Weekly: Private equity slows; SPAC underwriters retreat; carbon capture boost

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms


Clementia prices IPO

Clementia Pharmaceuticals Inc. priced its IPO of 8 million common shares at $15 per share.

The company also granted underwriters a 30-day option to buy up to an additional 1.2 million of the shares offered.

The shares will begin trading on the Nasdaq Global Select Market on Aug. 2 under the CMTA symbol. The offering is expected to close on Aug. 7.

Morgan Stanley & Co. LLC and Leerink Partners LLC are acting as book-running managers for the offering, while Wedbush Securities Inc. and BTIG LLC are acting as co-managers.